Last updated: 17 July 2019 at 9:43am EST

Leaf Ventures Ii, L.P.New L... Net Worth




The estimated Net Worth of Leaf Ventures Ii, L.P.New L... is at least 10.1 百万$ dollars as of 6 May 2013. Leaf L owns over 200,000 units of MEI Pharma Inc stock worth over 6,177,335$ and over the last 12 years Leaf sold MEIP stock worth over 3,897,904$.

Leaf L MEIP stock SEC Form 4 insiders trading

Leaf has made over 2 trades of the MEI Pharma Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Leaf sold 200,000 units of MEIP stock worth 1,716,000$ on 6 May 2013.

The largest trade Leaf's ever made was selling 257,300 units of MEI Pharma Inc stock on 18 April 2013 worth over 2,181,904$. On average, Leaf trades about 228,650 units every 9 days since 2013. As of 6 May 2013 Leaf still owns at least 2,045,475 units of MEI Pharma Inc stock.

You can see the complete history of Leaf L stock trades at the bottom of the page.



Insiders trading at MEI Pharma Inc

Over the last 12 years, insiders at MEI Pharma Inc have traded over 26,282,680$ worth of MEI Pharma Inc stock and bought 597,450 units worth 2,541,200$ . The most active insiders traders include Ventures Vii, Llc Vivo Vent...Leaf Ventures Ii, L.P.New L...Josiah T Austin. On average, MEI Pharma Inc executives and independent directors trade stock every 91 days with the average trade being worth of 360,383$. The most recent stock trade was executed by Funds Management Lp Anson A... on 22 September 2023, trading 48,060 units of MEIP stock currently worth 329,211$.



What does MEI Pharma Inc do?

mei pharma (nasdaq: meip) is a san diego-based oncology company focused on the clinical development of novel therapies for cancer. our lead drug candidate is pracinostat, a potential best-in-class, oral hdac inhibitor that has been granted breakthrough therapy designation from the fda in combination with azacitidine for the treatment of patients with newly diagnosed aml who are ≥75 years of age or unfit for intensive chemotherapy. our pipeline of drug candidates also includes me-401 (formerly pwt143), a next-generation oral pi3k delta inhibitor, and me-344, a novel mitochondrial inhibitor. for more, please go to www.meipharma.com.



Complete history of Leaf L stock trades at MEI Pharma Inc

インサイダー
取引
取引
合計金額
Leaf Ventures Ii, L.P.New L...
販売 1,716,000$
6 May 2013
Leaf Ventures Ii, L.P.New L...
販売 2,181,904$
18 Apr 2013


MEI Pharma Inc executives and stock owners

MEI Pharma Inc executives and other stock owners filed with the SEC include: